The emergence of sex differences in PTSD symptoms across development: evidence from the ALSPAC cohort.
ALPSAC
PTSD
childhood/adolescence
longitudinal
sex-differences
Journal
Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
pubmed:
15
8
2019
medline:
4
6
2021
entrez:
15
8
2019
Statut:
ppublish
Résumé
Cross-sectional evidence suggests females in late adolescence exhibit higher rates of post-traumatic stress symptoms (PTSS) than males and younger age groups. However, longitudinal evidence is limited, and underlying factors are not well understood. We investigated the emergence of sex differences in PTSS from childhood to adolescence in a large, longitudinal UK cohort, and tested whether these could be explained by overlap between PTSS and depressive symptoms, or onset of puberty. Trauma exposure and PTSS were assessed at ages 8, 10, 13 (parent-report) and 15 (self-report) years in a sub-sample of 9966 children and adolescents from the ALSPAC cohort-study. Analyses of PTSS focused on those who reported potential trauma-exposure at each time-point (ranged from n = 654 at 15 years to n = 1231 at 10 years). Age at peak-height velocity (APHV) was used as an indicator of pubertal timing. There was no evidence of sex differences in PTSS at ages 8 and 10, but females were more likely to show PTSS at ages 13 (OR 1.54, p = 0.002) and 15 (OR 2.04, p = .001), even once symptoms related to depression were excluded. We found little evidence that the emergence of sex differences was related to pubertal timing (as indexed by APHV). Results indicate that females show higher levels of PTSS in adolescence but not during childhood. The emergence of this sex difference does not seem to be explained by overlap with depressive symptoms, while the influence of pubertal status requires further investigation.
Sections du résumé
BACKGROUND
Cross-sectional evidence suggests females in late adolescence exhibit higher rates of post-traumatic stress symptoms (PTSS) than males and younger age groups. However, longitudinal evidence is limited, and underlying factors are not well understood. We investigated the emergence of sex differences in PTSS from childhood to adolescence in a large, longitudinal UK cohort, and tested whether these could be explained by overlap between PTSS and depressive symptoms, or onset of puberty.
METHODS
Trauma exposure and PTSS were assessed at ages 8, 10, 13 (parent-report) and 15 (self-report) years in a sub-sample of 9966 children and adolescents from the ALSPAC cohort-study. Analyses of PTSS focused on those who reported potential trauma-exposure at each time-point (ranged from n = 654 at 15 years to n = 1231 at 10 years). Age at peak-height velocity (APHV) was used as an indicator of pubertal timing.
RESULTS
There was no evidence of sex differences in PTSS at ages 8 and 10, but females were more likely to show PTSS at ages 13 (OR 1.54, p = 0.002) and 15 (OR 2.04, p = .001), even once symptoms related to depression were excluded. We found little evidence that the emergence of sex differences was related to pubertal timing (as indexed by APHV).
CONCLUSIONS
Results indicate that females show higher levels of PTSS in adolescence but not during childhood. The emergence of this sex difference does not seem to be explained by overlap with depressive symptoms, while the influence of pubertal status requires further investigation.
Identifiants
pubmed: 31409434
doi: 10.1017/S0033291719001971
pii: S0033291719001971
pmc: PMC7408572
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1755-1760Subventions
Organisme : Medical Research Council
ID : MC/UU/12013/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 102215/2/13/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M009351/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Références
Psychol Med. 1999 Jul;29(4):813-21
pubmed: 10473308
Int J Epidemiol. 2013 Feb;42(1):111-27
pubmed: 22507743
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6
pubmed: 9255702
Clin Psychol Rev. 2012 Mar;32(2):122-38
pubmed: 22245560
Am J Epidemiol. 2018 Apr 1;187(4):677-686
pubmed: 29020129
Biol Psychiatry. 2018 May 15;83(10):876-885
pubmed: 29331353
Psychol Bull. 2006 Nov;132(6):959-92
pubmed: 17073529
J Child Psychol Psychiatry. 2000 Jul;41(5):645-55
pubmed: 10946756
Int J Dev Sci. 2013;7(2):105-116
pubmed: 26052478
Arch Gen Psychiatry. 1995 Dec;52(12):1048-60
pubmed: 7492257
J Am Acad Child Adolesc Psychiatry. 1991 Nov;30(6):945-51
pubmed: 1757444
J Am Acad Child Adolesc Psychiatry. 2002 Feb;41(2):190-8
pubmed: 11837409
Front Neuroendocrinol. 2018 Oct;51:132-145
pubmed: 29932958
Wellcome Open Res. 2018 Jul 25;3:90
pubmed: 30345378
Paediatr Child Health. 2008 Jul;13(6):479-86
pubmed: 19436431
Arch Womens Ment Health. 2004 Apr;7(2):111-21
pubmed: 15083346
Curr Psychiatry Rep. 2017 Sep 30;19(11):87
pubmed: 28965303
J Clin Res Pediatr Endocrinol. 2015 Sep;7(3):235-7
pubmed: 26831559
Epidemiology. 2013 Jan;24(1):1-9
pubmed: 23211345
Child Adolesc Psychiatr Clin N Am. 2006 Oct;15(4):919-37, ix
pubmed: 16952768
Psychol Bull. 2007 Mar;133(2):183-204
pubmed: 17338596
Int J Epidemiol. 2013 Feb;42(1):97-110
pubmed: 22507742